We further uncovered new regulators of GLP-1 receptor-mediated signaling and insulinotropic responses in cells
It is also unclear whether patients would have to take these drugs for the rest of their lives or in combination with other procedures and therapies
Any changes to GLP-1 dosing, including maintenance or micro-dosing, should be done under medical supervision to ensure safety, effectiveness, and personalized care.
The World Obesity Atlas 2023 projects that by 2035, over 4 billion people globally could be classified as overweight or obese, a sharp increase from 2.6 billion in 2020
To reduce differences between treatment groups, investigators used propensity score matching , creating 226 matched pairs of patients based on their clinical characteristics
Glucose-6-phosphate dehydrogenase deficiency and risk of colorectal cancer in Northern Sardinia: a retrospective observational study